Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis

BACKGROUND: Bixalomer (BXL) was developed to improve gastrointestinal symptoms and reduce constipation, relative to sevelamer hydrochloride, in hemodialysis patients. We prospectively evaluated the safety and effectiveness of switching maintenance dialysis patients from sevelamer hydrochloride to BX...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatakeyama, Shingo, Murasawa, Hiromi, Narita, Takuma, Oikawa, Masaaki, Fujita, Naoki, Iwamura, Hiromichi, Mikami, Joutaro, Kojima, Yuta, Sato, Tendo, Fukushi, Ken, Ishibashi, Yusuke, Hashimoto, Yasuhiro, Koie, Takuya, Saitoh, Hisao, Funyu, Tomihisa, Ohyama, Chikara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852730/
https://www.ncbi.nlm.nih.gov/pubmed/24119202
http://dx.doi.org/10.1186/1471-2369-14-222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852730/
https://www.ncbi.nlm.nih.gov/pubmed/24119202
http://dx.doi.org/10.1186/1471-2369-14-222

Ejemplares similares